News
While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...
One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...
2d
The Print on MSNMounjaro vs Wegovy: Guess which obesity drug outperformed the other by a mile in head-to-head trialBoth medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...
7h
Everyday Health on MSNZebound Beats Wegovy for Weight Loss in First Head-to-Head TrialIn a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
3d
inews.co.uk on MSNWhy you might be given the ‘second-best’ weight loss drugAs the definitive trial comparing Wegovy to Mounjaro is released, experts stress the need for patients to be given the very ...
Novo Nordisk will present data at the European Congress of Obesity (ECO) from a secondary, post hoc analysis of the SELECT ...
Obesity is linked to 13 different cancers. Scientists have long known that losing weight can slash the risk of cancer, but ...
The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...
Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results